(BANGKOK, Sep 12, 2011) Bionor Pharma presented Vacc-4x on “Global HIV Vaccine Enterprise” press conference at AIDS Vaccine 2011 in Bangkok
Bionor Pharma was the only company with therapeutic HIV-vaccine having a presentation at Global HIV Vaccine Enterprise (GHVE) press conference, where the aim was to present promising HIV projects.
GHVE is a unique alliance of organizations that has the convening power to bring together an inclusive global alliance of top researchers, funders, advocacy groups, and stakeholders to catalyze fresh thinking, set new directions and advance global cooperation to develop an HIV vaccine.
Professor Jan van Lunzen, Medical Director Infectious Diseases at Hamburg-Eppendorf University, who is one of the investigators in the Vacc-4x phase IIB study, presented Vacc-4x on behalf of Bionor.
Link to a video of the press conference